By TOM MURPHY AP Health Writer Johnson & Johnson will spend more than $14 billion to delve further into the treatment of central nervous system disorders by purchasing Intra-Cellular Therapies. The health care giant said Monday that it will pay $132 in cash for each share of Intra-Cellular. That represents a 39% premium to Intra-Cellular’s […]
Johnson & Johnson Buys Intra-Cellular in $14.6B Deal Business Journal Daily | The Youngstown Publishing Company.
Read More Details
Finally We wish PressBee provided you with enough information of ( Johnson & Johnson Buys Intra-Cellular in $14.6B Deal )
Also on site :
- Today’s NYT ‘Strands’ Hints, Spangram and Answers for Monday, June 9
- Israel Detains Greta Thunberg, Other Activists After Halting Gaza-Bound Aid Ship
- Israel blocks Greta Thunberg’s ship from reaching Gaza, group says